These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 10025574)
1. A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy. Urakami K; Mori M; Wada K; Kowa H; Takeshima T; Arai H; Sasaki H; Kanai M; Shoji M; Ikemoto K; Morimatsu M; Hikasa C; Nakashima K Neurosci Lett; 1999 Jan; 259(2):127-9. PubMed ID: 10025574 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy. Urakami K; Wada K; Arai H; Sasaki H; Kanai M; Shoji M; Ishizu H; Kashihara K; Yamamoto M; Tsuchiya-Ikemoto K; Morimatsu M; Takashima H; Nakagawa M; Kurokawa K; Maruyama H; Kaseda Y; Nakamura S; Hasegawa K; Oono H; Hikasa C; Ikeda K; Yamagata K; Wakutani Y; Takeshima T; Nakashima K J Neurol Sci; 2001 Jan; 183(1):95-8. PubMed ID: 11166802 [TBL] [Abstract][Full Text] [Related]
3. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration. Yoshida M Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031 [TBL] [Abstract][Full Text] [Related]
14. A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. Borroni B; Malinverno M; Gardoni F; Grassi M; Parnetti L; Agosti C; Alberici A; Premi E; Bonuccelli U; Gasparotti R; Calabresi P; Di Luca M; Padovani A J Alzheimers Dis; 2010; 22(1):195-203. PubMed ID: 20847421 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Arai H; Morikawa Y; Higuchi M; Matsui T; Clark CM; Miura M; Machida N; Lee VM; Trojanowski JQ; Sasaki H Biochem Biophys Res Commun; 1997 Jul; 236(2):262-4. PubMed ID: 9240421 [TBL] [Abstract][Full Text] [Related]
16. Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD. Robinson JL; Yan N; Caswell C; Xie SX; Suh E; Van Deerlin VM; Gibbons G; Irwin DJ; Grossman M; Lee EB; Lee VM; Miller B; Trojanowski JQ J Neuropathol Exp Neurol; 2020 Mar; 79(3):296-304. PubMed ID: 31999351 [TBL] [Abstract][Full Text] [Related]
17. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Komori T; Arai N; Oda M; Nakayama H; Mori H; Yagishita S; Takahashi T; Amano N; Murayama S; Murakami S; Shibata N; Kobayashi M; Sasaki S; Iwata M Acta Neuropathol; 1998 Oct; 96(4):401-8. PubMed ID: 9797005 [TBL] [Abstract][Full Text] [Related]
18. Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Wakabayashi K; Takahashi H Neuropathology; 2004 Mar; 24(1):79-86. PubMed ID: 15068177 [TBL] [Abstract][Full Text] [Related]